Table 2

Clinical data

Patient	Diagnosis	Age (years)	Sex	pOx	Symptoms	Medications	WHO class
ASD, atrial septal defect; DILV, double inlet left ventricle; DOE, dyspnoea on exertion; DORV, double outlet right ventricle; F, female; M, male; PDA, persistent ductus arteriosus; pOx, pulse oximetry; TGA, transposition of the great arteries; VSD, ventricular septal defect; WHO, World Health Organization.
1	Aortopulmonary window	31	F	93%	DOE, cyanosis	None	III
2	VSD	28	M	86%	DOE, cyanosis	Warfarin	III
3	Aortopulmonary window	14	M	87%	DOE, cyanosis	None	III
4	VSD	15	M	90%	DOE, cyanosis	None	III
5	DORV, VSD	43	M	75%	DOE, cyanosis	Warfarin	IV
6	Aortopulmonary window	19	M	85%	DOE, cyanosis	None	III
7	VSD	9	M	96%	DOE, exertion cyanosis	None	II
8	VSD, PDA, Down’s syndrome	6	F	95%	DOE	None	II
9	PDA	40	F	96%	DOE	Digoxin, warfarin, furosemide	III
10	Congenitally corrected TGA, VSD	10	M	98%	DOE	Furosemide	II
11	VSD, small PDA	22	F	92%	DOE, cyanosis	Warfarin	III
12	Atrioventricular canal, Down’s syndrome	30	F	74%	DOE, cyanosis	None	III
13	VSD	35	F	66%	DOE, cyanosis	Warfarin	III
14	DORV, VSD	22	M	90%	DOE, cyanosis	None	III
15	DORV, VSD, TGA	19	M	82%	DOE, cyanosis	Warfarin	III
16	DILV, TGA	16	F	78%	DOE, cyanosis	Warfarin	III
17	DILV, TGA	9	F	80%	DOE, cyanosis	Digoxin, furosemide	II
18	ASD	36	F	73%	DOE, cyanosis	Warfarin, oxygen	IV
19	VSD, PDA, repaired at 20 years	43	M	95%	DOE, atrial flutter	Warfarin, amiodarone	IV
20	TGA, VSD, repaired at 15 days	12	M	98%	DOE	None	II
21	VSD repaired at 8 months, ASD	8	F	72%	DOE, cyanosis	Warfarin, oxygen	IV